Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Cantor Fitzgerald
Boehringer Ingelheim
AstraZeneca
Dow
Accenture
Cerilliant
Cipla
Chinese Patent Office

Generated: August 19, 2017

DrugPatentWatch Database Preview

Oxaprozin potassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxaprozin potassium and what is the scope of oxaprozin potassium freedom to operate?

Oxaprozin potassium
is the generic ingredient in one branded drug marketed by Gd Searle and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin potassium.

Summary for Generic Name: oxaprozin potassium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list13
Bulk Api Vendors: see list2
Clinical Trials: see list602
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxaprozin potassium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle
DAYPRO ALTA
oxaprozin potassium
TABLET;ORAL020776-001Oct 17, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: oxaprozin potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle
DAYPRO ALTA
oxaprozin potassium
TABLET;ORAL020776-001Oct 17, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Harvard Business School
Cantor Fitzgerald
US Army
Chinese Patent Office
Fish and Richardson
Deloitte
Merck
Accenture
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot